home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stocks That Hit 52-Week Lows On Tuesday ↗

October 04, 2022

On Tuesday, 44 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 20, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 19, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.

Via Benzinga

ReShape Lifesciences' GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Procedures ↗

August 10, 2022

Via Benzinga

Recap: Reshape Lifesciences Q1 Earnings ↗

May 23, 2022

Reshape Lifesciences (NASDAQ:RSLS) reported its Q1 earnings results on Monday, May 23, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Reshape Lifesciences's Return On Capital Employed Overview ↗

September 09, 2022

Benzinga Pro data, Reshape Lifesciences (NASDAQ:RSLS) reported Q2 sales of $2.89 million. Earnings fell to a loss of $9.58 million, resulting in a 16.57% decrease from last quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 02, 2022

On Friday, 122 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 16, 2022

On Tuesday, 37 stocks hit new 52-week lows.

Via Benzinga

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

Reshape Lifesciences Earnings Outlook ↗

August 12, 2022

Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 10, 2022

Via Benzinga

ReShape Lifesciences Shares Soar As FDA Announced Clearance To GIBI HD Calibration Tubes In Weight Loss Procedures ↗

August 10, 2022

The U.S. Food and Drug Administration (FDA) has announced 510(k) clearance to ReShape Lifesciences’ (NASDAQ: RSLS) Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for use in gastric and...

Via Benzinga

ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer

July 27, 2022

From ReShape Lifesciences Inc

Via GlobeNewswire

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗

August 01, 2022

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 26, 2022

On Tuesday, 120 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 27, 2022

Wednesday saw 83 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 25, 2022

On Monday, 100 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

Reshape Lifesciences Earnings Perspective: Return On Capital Employed ↗

June 23, 2022

According to data from Benzinga Pro, during Q1, Reshape Lifesciences's (NASDAQ:RSLS) reported sales totaled $2.44 million. Despite a 76.83% increase in earnings, the company posted a loss of $8.21...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 17, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 09, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 31, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

Earnings Scheduled For May 23, 2022 ↗

May 23, 2022

Companies Reporting Before The Bell • Star Equity Hldgs (NASDAQ:STRR) is expected to report quarterly loss at $0.15 per share on revenue of $25.45 million.

Via Benzinga

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗

May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Via Benzinga

Earnings Outlook For Reshape Lifesciences ↗

May 20, 2022

Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Reshape...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 09, 2022

Via Benzinga

ReShape Lifesciences(TM) (NASDAQ: RSLS) Featured in Coverage of Investor Summit Group’s Q2 Virtual Event

May 05, 2022

Via Investor Brand Network

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com